Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Will generative artificial intelligence’s star be added to the Hollywood Walk of Fame? Andreessen Horowitz sure thinks so.
Budget-friendly Spirit Airlines hasn’t reported an annual profit since 2019, and has lost some $2.2 billion since 2020.
The Trump White House may usher in a big loosening of the rules around cars that can operate without human drivers.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Snacking conglomerates all agree: Petcare mergers and acquisitions are the cat’s pajamas. Just ask General Mills.
Has Bob Iger now done it? Has he restored the magic, the thing defeated activist agitator Carl Icahn said was missing?
Charging infrastructure remains a barrier in EV adoption.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Honeywell may just be the next conglomerate to split into various pieces. At least if Elliott Investment Management has its way.
A treasure trove of genetic data may hold the key to a revolution in drug development, but it offers no clues for building a business.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.